Catecholaminergic regulation of the hypothalamic-pituitary-adrenocortical activity

• Autorzy: Bugajski J. , Turon M. , Gadek-Michalska A. , Borycz J. A.
• Języki publikacji: EN

Abstrakty

EN

The significance and site of adrenergic receptors involved in the control of the hypothalamic-pituitary-adrenal axis (HPA) activity was assessed indirectly by estimation of serum corticosterone levels 1 h after drug administration to conscious rats. Adrenergic drugs were given intracerebroventricularly (icv) and intraperito neally (ip), the antagonists 15 min prior to the agonists. Noradrenaline, adrenalin and isoproterenol given by either route increased dosedependently the serum corticosterone levels. The corticosterone response to icv noradrenaline was almost abolished by icv pretreatment with propranolol, a ß-adrenergic antagonist, and yohimbine, an α₂ -receptor blocker, and was also considerably reduced by prazosin, an α₂- adrenergic antagonist. When given ip, these antagonists did not significantly influence the noradrenaline induced corticosterone response, which suggests a suprapituitary site of action of noradrenaline in stimulation of the HPA. The corticosterone response to icv adrenalin was suppressed by prazosin given by either route. The corticosterone response to ip adrenalin was almost abolished by pretreatment with yohimbine, and also significantly diminished by propranolol given by the same route. The increase in corticosterone secretion, induced by isoproterenol given by either route, was abolished by ip injection of propranolol. These results indicate that noradrenaline stimulates the HPA via α and ß-adrenergic receptors, mainly at the suprapituitary level. Adrenalin increases that activity both via central and pituitary a and ß-adrenoceptors. Isoproterenol activates the HPA by stimulation of pituitary ß-receptors.

Słowa kluczowe

EN

catecholamine; pituitary-adrenocortical activity; corticosterone; adrenergic receptor; hypothalamic-pituitary-adrenal axis; noradrenaline; adrenaline; isoproterenol; beta-adrenergic antagonist; yohimbine; prazosin; rat

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 1991
• Tom: 42
• Numer: 1
• Opis fizyczny: p.93-103,fig.,ref.

Twórcy

autor

Bugajski J.

• Department of Physiology, Institute of Pharmacology, Polish Academy of Sciences, 12 Smetna Str., 31-343 Krakow, Poland

autor

Turon M.

• Department of Physiology, Institute of Pharmacology, Polish Academy of Sciences, 12 Smetna Str., 31-343 Krakow, Poland

autor

Gadek-Michalska A.

• Department of Physiology, Institute of Pharmacology, Polish Academy of Sciences, 12 Smetna Str., 31-343 Krakow, Poland

autor

Borycz J. A.

• Department of Physiology, Institute of Pharmacology, Polish Academy of Sciences, 12 Smetna Str., 31-343 Krakow, Poland

Bibliografia

• 1. Al-Damluji S. Adrenergic mechanisms in the control of corticotrophin secretion. J. Endocr. 1988; 119: 5-14.
• 2. Plotsky PM, Cunningham ET, Widmaier EP. Catecholaminergic modulation of corticotropinreleasing factor and adrenocorticotropin secretion. Endocrine Rev 1989; 10: 437-458.
• 3. Proulx L. Giguere V. Cote J, Labrie F. Multiple factors involved in the control of ACTH secretion. J Endocrinol Invest 1984; 7 : 257-263.
• 4. Liposits Zs, Phelix C, Pauli WK. Adrenergic innervation of corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. Histochemistry 1986; 84: 201-205.
• 5. Takao T, Hashimoto K, Ota Z. Central catecholaminergic control of ACTH secretion. Regulatory Peptides 1988; 21: 301-308.
• 6. Tilders FJH, Berkenbosch F, Veraies I, Linton EA, Smelik PG. Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress. Federation Proc 1985; 44: 44:155-160.
• 7. Wynn PC, Harwood JP, Catt KJ, Aguilera G. Regulation of corticotropinreleasing factor (CRF) receptors in the rat pituitary gland: effects of adrenalectomy on CRF receptors and corticotroph responses. Endocrinology 1985; 116: 1653-1659.
• 8. Ganong WF. Neurotransmitters and pituitary function: regulation of ACTH secretion. Federation Proc 1980; 39: 2923-2930.
• 9. Suda T, Yajima F, Tomori N, Sumitomo T, Nakagami Y, bshiyama T, Demura H, Shizume K. Inhibitory effect of norepinephrine on immunoreactive corticotropinreleasing factor release from the rat hypothalamus in vitro. Life Sci 1987; 40: 1645-1649.
• 10. Leibowitz SF, Sladek C, Spencer L, Tempel D. Neuropeptide Y, epinephrine and norepinephrine in the paraventricular nucleus: stimulation of feeding and the release of corticosterone, vasopressin and glucose. Brain Res Bull. 1988; 21: 905-912.
• 11. Paradisi R, Frank G, Grossi G, Venturoli S, Porcu E, Capelli M, Galassi E, Flamigni C. High concentration of catecholamines in human hypothalamichypophysial blood. J. Clin Invest 1989; 83: 2079-2084.
• 12. Plotsky PM. Facilitation of immunoreactive corticotropinreleasing factor secretion into the hypophysialportal circulation afxr activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology 1987; 121: 924-930.
• 13. Spinedi E, Johnston CA, Chisari A, NegroVilar A. Role of central epinephrine on the regulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocrinology 1988; 122: 1977-1983.
• 14. Leibowitz SF, Diaz S, Tempel D. Norepinephrine in the paraventricular nucleus stimultes corticosterone release. Brain Res 1989; 496: 219-227.
• 15. Sato M, Kubota Y, Malbon CC, Tohyama M. Immunohistochemical evidence that most rat corticotrophs contain be a-adrenergic receptors, Neuroendocrinoiogy 1989; 50: 577-583.
• 16. Mezey E, Reisine TD, Palkovits M, Brownstein MJ, Axelrod J. Direct stimulation of ß₂ adrenergic receptors in rat anterior pituitary induces the release of adrenocorticotropin in vivo. Proc Natl Acad Sci USA 1983; 80: 6728-6731.
• 17. Mezey E, Reisine TD, Brownstein MJ, Palkovits M, Axelrod J. ß-adrenergic mechanism of insulininduced adrenocorticotropin release from the anterior pituitary. Science 1984 ; 226: 1085-1087.
• 18. Bugajski J, Janusz Z. Central histaminergic stimulation of pituitary-adrenocortical response in the rat. Life Sci 1983; 33: 1179-1189.
• 19. Saphier D, Feldman S. Adrenoceptor specificity in the central regulation of adrenocortical secretion. Neuropharmacology 1989; 28: 1231-1237.
• 20. Gądek-Michalska A, Turoń M, Bugajski J, Połczyńska-Konior G. Effects of systemic and intracerebroventricular phenylephrine and clonidine on corticosterone secretion in rats. Endocrinologia Experimentalis 1990; 24: 249-257.
• 21. Vale W, Vaughan J, Smith M, Yamamoto G, Rivier J, Rivier C. Effects of synthetic ovine corticotropinieleasing factor, glucocorticoids, catecholamines, neurohypophysial peptides and other substances on cultured corticotropin cell. Endocrinology 1983; 113: 1121-1131.
• 22. Grunhaus L, Tiongco D, Zelnik T, Felgel P, Hollingsworth PJ, Smith CB. Intravenous yohimbine; selective enhancer of norepinephrine and cortisol secretion and systolic blood pressure in humans, Clin Neuropharmacol 1989; 12;106-114.
• 23. Zacny, E, Bugajski J. Effect of intracerebroventricular clonidine on serum corticosterone levels in rats. Horm Res 1984; 20: 116-123.
• 24. De Souza. Beta-2-adrenergic receptors in pituitary. Neuroendocrinology 1985; 41: 289-296.
• 25. Dashwood MR, Central and peripheral prazosin binding: an in vitro autoradiographic study in the rat. Eur J Pharmacol 1983; 86: 51-58.
• 26. Barnabel G, Ixart G, Malaval F, Mas N, Didier M, Assenmacher I. Intracerebroventricular infusion of adrenaline stimulates tin release of corticotropinreleasinghormone (CRH₄₁) in the pushpull cannulated median eminence of unanesthetized rats. C R Acad Sci Paris 1987; 305: 703-708.
• 27. Plotsky PM, Otto S, Sutton S. Neurotransmitter modulation of corticotropin releasing factor secretion into the hypophysialportal circulation. Life Sci 1987; 41: 1311-1317.
• 28. Szafarczyk A, Malaval F, Laurent A, Gibaud R, Assenmacher I. Further evidence for a central stimulatory action of catecholamines on adrenocorticotropin release in the rat. Endocrinology 1986; 121: 883-892.